ketoconazole has been researched along with bosutinib in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
Abbas, R; Burns, J; Hug, BA; Leister, C; Sonnichsen, D | 1 |
Abbas, R; Hug, BA; Leister, C; Sonnichsen, D | 1 |
Abbas, R; Chalon, S; El Gaaloul, M; Leister, C; Sonnichsen, D | 1 |
Abbas, R; Hsyu, PH; Loi, CM; Ono, C; Yamazaki, S | 1 |
Costales, C; Kimoto, E; Loi, CM; Varma, MV; Yamazaki, S | 1 |
1 review(s) available for ketoconazole and bosutinib
Article | Year |
---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
3 trial(s) available for ketoconazole and bosutinib
Article | Year |
---|---|
Effect of ketoconazole on the pharmacokinetics of oral bosutinib in healthy subjects.
Topics: Administration, Oral; Adult; Aniline Compounds; Antifungal Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Ketoconazole; Male; Middle Aged; Nitriles; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinolines; Young Adult | 2011 |
A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects.
Topics: Adolescent; Adult; Aniline Compounds; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart; Humans; Ketoconazole; Male; Middle Aged; Moxifloxacin; Nitriles; Quinolines; Young Adult | 2012 |
Ascending single-dose study of the safety profile, tolerability, and pharmacokinetics of bosutinib coadministered with ketoconazole to healthy adult subjects.
Topics: Administration, Oral; Adolescent; Adult; Aniline Compounds; Antifungal Agents; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Humans; Ketoconazole; Male; Middle Aged; Nitriles; Protein Kinase Inhibitors; Quinolines; Young Adult | 2012 |
2 other study(ies) available for ketoconazole and bosutinib
Article | Year |
---|---|
Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease Interactions.
Topics: Administration, Oral; Aniline Compounds; Area Under Curve; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Ketoconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Models, Biological; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Quinolines; Rifampin; src-Family Kinases; Treatment Outcome | 2017 |
Application of Physiologically Based Pharmacokinetic Modeling in Understanding Bosutinib Drug-Drug Interactions: Importance of Intestinal P-Glycoprotein.
Topics: Administration, Oral; Aniline Compounds; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Intestinal Mucosa; Ketoconazole; Male; Nitriles; Quinolines; Rifampin | 2018 |